Mark Stanley Berger - Net Worth and Insider Trading
Mark Stanley Berger Net Worth
The estimated net worth of Mark Stanley Berger is at least $1,147 dollars as of 2024-04-28. Mark Stanley Berger is the Chief Medical Officer of Actinium Pharmaceuticals Inc and owns about 167 shares of Actinium Pharmaceuticals Inc (ATNM) stock worth over $1,147. Details can be seen in Mark Stanley Berger's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark Stanley Berger has not made any transactions after 2017-06-15 and currently still holds the listed stock(s).
Transaction Summary of Mark Stanley Berger
Mark Stanley Berger Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Stanley Berger owns 2 companies in total, including Actinium Pharmaceuticals Inc (ATNM) , and Genprex Inc (GNPX) .
Click here to see the complete history of Mark Stanley Berger’s form 4 insider trades.
Insider Ownership Summary of Mark Stanley Berger
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATNM | Actinium Pharmaceuticals Inc | 2017-06-15 | Chief Medical Officer |
| GNPX | Genprex Inc | 2021-09-27 | Chief Medical Officer |
Mark Stanley Berger Latest Holdings Summary
Mark Stanley Berger currently owns a total of 1 stock. Mark Stanley Berger owns 167 shares of Actinium Pharmaceuticals Inc (ATNM) as of June 15, 2017, with a value of $1,147.
Latest Holdings of Mark Stanley Berger
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATNM | Actinium Pharmaceuticals Inc | 2017-06-15 | 167 | 6.87 | 1,147 |
Holding Weightings of Mark Stanley Berger
Mark Stanley Berger Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Stanley Berger has made a total of 0 transactions in Actinium Pharmaceuticals Inc (ATNM) over the past 5 years. The most-recent trade in Actinium Pharmaceuticals Inc is the acquisition of 167 shares on June 15, 2017, which cost Mark Stanley Berger around $5,550.
Insider Trading History of Mark Stanley Berger
- 1
Mark Stanley Berger Trading Performance
GuruFocus tracks the stock performance after each of Mark Stanley Berger's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Stanley Berger is -44.35%. GuruFocus also compares Mark Stanley Berger's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Stanley Berger within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Stanley Berger's insider trading performs compared to the benchmark.
Performance of Mark Stanley Berger
Average Return
-56.52%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8.7 | -44.35 | -44.35 | -56.52 | -53.99 | -29.27 |
| Relative Return to S&P 500(%) | -9.8 | -47.14 | -54.35 | -70.79 | -62.95 | -37.29 |
Mark Stanley Berger Ownership Network
Ownership Network List of Mark Stanley Berger
Ownership Network Relation of Mark Stanley Berger
Mark Stanley Berger Owned Company Details
What does Actinium Pharmaceuticals Inc do?
Who are the key executives at Actinium Pharmaceuticals Inc?
Mark Stanley Berger is the Chief Medical Officer of Actinium Pharmaceuticals Inc. Other key executives at Actinium Pharmaceuticals Inc include VP & Finance and Corporate Dev. Steve O'loughlin , Chief Scientific Officer Dale L. Ludwig , and Chief Commercial Officer Anil Kapur .
Actinium Pharmaceuticals Inc (ATNM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Actinium Pharmaceuticals Inc (ATNM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Actinium Pharmaceuticals Inc (ATNM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Actinium Pharmaceuticals Inc (ATNM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Actinium Pharmaceuticals Inc Insider Transactions
Mark Stanley Berger Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Stanley Berger. You might contact Mark Stanley Berger via mailing address: 140 Riverside Drive, Apt. 9k, New York Ny 10024.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
